SANDERSON DESIGN GROUP PLC
SDG | IL
Overview
Corporate Details
- ISIN(s):
- GB0003061511
- LEI:
- 213800A8K2WOUZJIQL93
- Country:
- United Kingdom
- Address:
- VOYSEY HOUSE, W4 4DS LONDON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Sareum Holdings PLC is a clinical-stage biotech developing next-generation kinase inhibitors for autoimmune diseases & cancer.Ê Our focus is on TYK2/JAK1 inhibitors, with lead candidate SDC-1801 in Phase 1a/b trials for psoriasis and SDC-1802 for cancer immunotherapy.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-03 14:24 |
Declaration of Voting Results & Voting Rights Announcements
Vesting of Awards under LTIP & Total Voting Rights
|
English | 34.0 KB | |
| 2025-06-02 08:00 |
Report Publication Announcement
Annual Report and Notice of AGM
|
English | 16.8 KB | |
| 2025-03-13 16:11 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 22.2 KB | |
| 2025-02-17 12:59 |
Directors' Dealings
Notification of Director Share Ownership
|
English | 30.4 KB | |
| 2025-02-03 17:55 |
Board/Management Change
Non-Executive Board Change
|
English | 15.6 KB | |
| 2025-01-22 17:05 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 22.4 KB | |
| 2025-01-20 18:18 |
Directors' Dealings
PDMR Share Purchase
|
English | 28.2 KB | |
| 2025-01-20 15:38 |
Directors' Dealings
Director Share Purchases
|
English | 31.5 KB | |
| 2025-01-20 08:00 |
Regulatory News Service
Trading Update
|
English | 19.8 KB | |
| 2024-12-19 08:00 |
Regulatory News Service
Sanderson awarded Royal Warrant
|
English | 16.8 KB | |
| 2024-12-02 12:45 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 43.3 KB | |
| 2024-12-02 12:15 |
Regulatory News Service
Total Voting Rights
|
English | 15.2 KB | |
| 2024-11-25 08:00 |
Regulatory News Service
Non-Executive Board Change
|
English | 15.9 KB | |
| 2024-11-13 17:05 |
Directors' Dealings
Director/PDMR Shareholding and Total Voting Rights
|
English | 33.0 KB | |
| 2024-11-04 08:00 |
Regulatory News Service
Senior Appointments in the UK and North America
|
English | 18.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN |